Beta amyloid protein has likely been transmitted on rare instances to people who received human growth hormone extract made from cadavers, a study finds. The protein, a key indicator of Alzheimer’s ...
A new King’s College London study finds a cancer drug may reverse brain connectivity changes linked to early Alzheimer’s ...
A new kind of cellular immunotherapy shows promise in preventing Alzheimer's-associated plaques from forming in the brain – ...
A team from the University of Barcelona has designed and validated in animal models an innovative compound with a pioneering mechanism of action for the treatment of Alzheimer's disease. Unlike ...
Scientists develop a blood test that detects Alzheimer’s by measuring protein structural changes rather than protein quantity.
Even one fall by an older adult is just as accurate in predicting cognitive decline as individuals with elevated amyloid, the ...
In people destined to get Alzheimer's in their mid-40s, one protein can delay the onset of the disease by about 20 years.
Morning Overview on MSN
Parkinson’s protein tied to faster Alzheimer’s tau buildup in women
A protein best known for its role in Parkinson’s disease may be speeding up Alzheimer’s-related brain damage in women. New research drawing on cerebrospinal fluid samples and brain imaging from a ...
The new generation of Alzheimer's disease drugs—the first proven to change the course of the disease—typically extend ...
Amyloid beta is a peptide that plays a central role in the neurodegenerative pathology of Alzheimer’s disease by aggregating into plaques in the brain. U.S. Food and Drug Administration (FDA) approved ...
A new study suggests Alzheimer’s disease may be detectable through subtle shape changes in proteins found in the blood.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results